×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
吉林大学白求恩第一医... [8]
复旦大学上海医学院 [1]
中国医学科学院 北京... [1]
合肥物质科学研究院 [1]
内容类型
期刊论文 [8]
会议论文 [3]
发表日期
2021 [1]
2018 [1]
2017 [2]
2015 [7]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
期刊论文
AUTOPHAGY, 2021, 卷号: 17
作者:
Klionsky, Daniel J.
;
Abdel-Aziz, Amal Kamal
;
Abdelfatah, Sara
;
Abdellatif, Mahmoud
;
Abdoli, Asghar
收藏
  |  
浏览/下载:278/0
  |  
提交时间:2021/05/31
Autophagosome
cancer
flux
LC3
lysosome
macroautophagy
neurodegeneration
phagophore
stress
vacuole
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial
期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 9
作者:
Goss, Glenwood D.
;
Felip, Enriqueta
;
Cobo, Manuel
;
Lu, Shun
;
Syrigos, Konstantinos
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Second-Line Afatinib versus Erlotinib for Patients with Squamous Cell Carcinoma of the Lung (LUX-Lung 8): Analysis of Tumor and Serum Biomarkers
会议论文
作者:
Isla, Dolores
;
Min, Young Joo
;
Ardizzoni, Andrea
;
Gadgeel, Shirish
;
Dupuis, Nicholas
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
Squamous cell carcinoma of the lung
NSCLC
afatinib
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer
期刊论文
2017, 卷号: 2, 期号: 3, 页码: e000219
作者:
Blackhall Fiona
;
Ross Camidge D
;
Shaw Alice T
;
Soria Jean-Charles
;
Solomon Benjamin J
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Alk
clinical trial
crizotinib
profile 1005
Afatinib (A) vs erlotinib (E) as second-line therapy of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following platinum-based chemotherapy: Overall survival (OS) analysis from the global phase III trial LUX-Lung 8 (LL8).
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 15
作者:
Soria, Jean-Charles
;
Felip, Enriqueta
;
Cobo, Manuel
;
Lu, Shun
;
Syrigos, Konstantinos N.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
A fatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial
会议论文
作者:
Gadgeel, Shirish
;
Soria, Jean-Charles
;
Felip, Enriqueta
;
Cobo, Manuel
;
Lu, Shun
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/05
Lung cancer / Oncology
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 15
作者:
Gadgeel, Shirish M.
;
Dols, Manuel Cobo
;
Felip, Enriqueta
;
Soria, Jean-Charles
;
Lee, Ki Hyeong
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/05
LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy
会议论文
作者:
Hirsh, Vera
;
Gadgeel, Shirish
;
Soria, Jean-Charles
;
Felip, Enriqueta
;
Cobo, Manuel
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: Patient-reported outcome (PRO) data from the LUX-Lung 8 Phase III global trial.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2015, 卷号: 33, 期号: 15
作者:
Gadgeel, Shirish M.
;
Dols, Manuel Cobo
;
Felip, Enriqueta
;
Soria, Jean-Charles
;
Lee, Ki Hyeong
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
期刊论文
LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 8
作者:
Soria, Jean-Charles
;
Felip, Enriqueta
;
Cobo, Manuel
;
Lu, Shun
;
Syrigos, Konstantinos
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
©版权所有 ©2017 CSpace - Powered by
CSpace